Lunaphore and Visiopharm: Partnership to unify spatial staining and imaging with AI analysis technologies in end-to-end solution for researchers studying cancer and other diseases. LAUSANNE, Switzerland and HØRSHOLM, Denmark – May 4, 2022...

Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Breast Cancer; ER. Adding to its repertoire of CE-IVD marked clinical AI models for cancer diagnostics, the new AI model automates the calculation of...

PARIS, France and CAMBRIDGE, Mass. – Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies,...

Visiopharm has announced preregistration for their USCAP 2022 seminar. AI-driven stain quality standardization of IHC Featuring Marilyn M. Bui, MD, Ph.D., Moffitt Cancer Center and Martin Kristensson, Visiopharm Wednesday, March 23rd,...

AIRA Matrix invites you to the 111th USCAP Annual Meeting, Los Angeles where we exhibit our novel Prostate Cancer Decision Support Suite from 21-23 March 2022. The suite comprising diagnostic, prognostic, and predictive solutions provides...

AIRA Matrix has published a new paper. Read on to learn more about their work. Our paper “A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies” has been published in the March...